4.7 Review

Depression as a Risk Factor for Alzheimer's Disease: A Systematic Review of Longitudinal Meta-Analyses

期刊

JOURNAL OF CLINICAL MEDICINE
卷 10, 期 9, 页码 -

出版社

MDPI
DOI: 10.3390/jcm10091809

关键词

depression; Alzheimer’ s disease; clinical and symptomatic criteria; meta-meta-analysis

资金

  1. Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness, Madrid, Spain [94/1562, 97/1321E, 98/0103, 01/0255, 03/0815, 06/0617, 12/02254, 16/00896, PI/19/01874, G03/128]
  2. Fondo Europeo de Desarrollo Regional (FEDER) of the European Union Una manera de hacer Europa [PI16/00896]
  3. Gobierno de Aragon [B15_17R]
  4. Miguel Servet program - Instituto de Salud Carlos III [CP20/00040]
  5. European Union (ERDF/ESF, Investing in your future)
  6. FEDER funds
  7. Spanish Ministry of Economy and Competitiveness [ECO2016-76567-C4-2-R, PID2019-104263RB-C44]
  8. Regional Government of Castilla y Leon, Spain [BU329U14, BU071G19]
  9. Regional Government of Castilla y Leon
  10. FEDER funds [BU062U16]

向作者/读者索取更多资源

The study found a significant association between depression and Alzheimer's disease, with clinical measures of depression showing a more consistent and significant effect size in predicting AD risk compared to symptomatic rating scales. The type of rating scale used to assess depression and the selected cut-off criteria also moderated the relationship between depression and AD risk.
Alzheimer's disease (AD) is the most frequent cause of dementia, linked to morbidity and mortality among elderly patients. Recently, several clinical studies suggested that depression is a potential risk factor for cognitive decline and AD. A review of meta-analyses was performed, calculating pooled odds ratios to estimate the risk of AD in people with a prior diagnosis (or clinically significant symptoms) of depression. A total of six meta-analyses which represented 28 individual studies were analyzed. A significant association between depression and AD was found (OR = 1.54, 95% CI [1.02-2.31]; p = 0.038). The results showed that heterogeneity across studies was substantial. We found a significant positive effect size for clinical measures of depression, but not for symptomatic rating scales, in the association of depression with risk of AD. The type of rating scale used to assess depression and the cut-off criteria selected also moderated the relationship between depression and AD risk. We found that studies that used clinically significant criteria for diagnosis of depression had more consistent and significant results than studies that used symptomatic scales.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据